Truist Financial Corp Buys 9,180 Shares of DaVita Inc. (NYSE:DVA)

Truist Financial Corp raised its stake in shares of DaVita Inc. (NYSE:DVA) by 54.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 26,068 shares of the company’s stock after purchasing an additional 9,180 shares during the period. Truist Financial Corp’s holdings in DaVita were worth $2,731,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the company. Hanseatic Management Services Inc. bought a new position in shares of DaVita during the 3rd quarter valued at approximately $36,000. GAMMA Investing LLC bought a new position in shares of DaVita in the 4th quarter valued at about $60,000. Federated Hermes Inc. grew its position in DaVita by 1,284.4% in the third quarter. Federated Hermes Inc. now owns 1,246 shares of the company’s stock worth $118,000 after acquiring an additional 1,156 shares in the last quarter. Tacita Capital Inc bought a new stake in DaVita during the third quarter worth approximately $118,000. Finally, CENTRAL TRUST Co raised its position in DaVita by 93.3% during the third quarter. CENTRAL TRUST Co now owns 1,448 shares of the company’s stock valued at $137,000 after purchasing an additional 699 shares during the period. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. StockNews.com downgraded DaVita from a “strong-buy” rating to a “buy” rating in a research report on Monday. Truist Financial upped their price target on shares of DaVita from $130.00 to $135.00 and gave the company a “hold” rating in a report on Tuesday, February 20th. Barclays raised their price objective on shares of DaVita from $133.00 to $150.00 and gave the stock an “equal weight” rating in a research note on Monday. TheStreet upgraded DaVita from a “c+” rating to a “b-” rating in a report on Wednesday, February 7th. Finally, UBS Group boosted their price objective on DaVita from $113.00 to $134.00 and gave the company a “buy” rating in a report on Wednesday, February 14th. Two equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $121.33.

Insider Transactions at DaVita

In related news, insider James O. Hearty sold 26,164 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $119.64, for a total value of $3,130,260.96. Following the completion of the transaction, the insider now owns 20,264 shares of the company’s stock, valued at $2,424,384.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other DaVita news, insider James O. Hearty sold 26,164 shares of DaVita stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $119.64, for a total value of $3,130,260.96. Following the transaction, the insider now owns 20,264 shares in the company, valued at $2,424,384.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Kathleen Alyce Waters sold 11,285 shares of the stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $120.73, for a total transaction of $1,362,438.05. Following the sale, the insider now directly owns 81,297 shares of the company’s stock, valued at $9,814,986.81. The disclosure for this sale can be found here. In the last quarter, insiders sold 134,540 shares of company stock valued at $16,551,071. Company insiders own 1.40% of the company’s stock.

DaVita Stock Up 0.7 %

Shares of NYSE:DVA opened at $137.79 on Wednesday. The company has a quick ratio of 1.37, a current ratio of 1.43 and a debt-to-equity ratio of 7.95. The business’s 50 day moving average is $134.15 and its 200 day moving average is $113.89. The stock has a market cap of $12.08 billion, a P/E ratio of 15.66, a price-to-earnings-growth ratio of 1.17 and a beta of 1.04. DaVita Inc. has a 52-week low of $71.51 and a 52-week high of $145.04.

DaVita (NYSE:DVA) last released its quarterly earnings data on Thursday, May 2nd. The company reported $2.38 earnings per share for the quarter, beating the consensus estimate of $1.95 by $0.43. DaVita had a return on equity of 68.52% and a net margin of 6.61%. The firm had revenue of $3.07 billion during the quarter, compared to the consensus estimate of $3.03 billion. During the same period in the previous year, the company posted $1.58 earnings per share. The firm’s quarterly revenue was up 6.9% on a year-over-year basis. Sell-side analysts predict that DaVita Inc. will post 9.49 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.